UMPC Hillman Cancer Center — Pittsburgh, Pennsylvania

UMPC Hillman Cancer Center is a clinical research site located in Pittsburgh, Pennsylvania, United States 15232.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

UMPC Hillman Cancer Center has participated in 2 clinical trials.

Therapeutic areas: Thrombocythemia, Essential, Primary Myelofibrosis, Solid Tumor, Adult.

Sponsors: Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA), Dragonfly Therapeutics.

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UMPC Hillman Cancer Center?

UMPC Hillman Cancer Center has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UMPC Hillman Cancer Center conducted?

UMPC Hillman Cancer Center has 2 clinical trials on record. Their work covers Thrombocythemia, Essential, Primary Myelofibrosis, Solid Tumor, Adult.

Is UMPC Hillman Cancer Center accredited by Crixeo Health?

UMPC Hillman Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UMPC Hillman Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.